Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Frontiers in Medicine|February 28, 2022
Expression of the Immune Checkpoint Protein VISTA Is Differentially Regulated by the TGF-β1 - Smad3 Signaling Pathway in Rapidly Proliferating Human Cells and T LymphocytesStephanie Schlichtner, Inna M Yasinska, Sabrina Ruggiero, et al.
Frontiers in Immunology|July 8, 2021
High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer CellsAnette Teo Hansen Selnø, Stephanie Schlichtner, Inna M Yasinska, et al.
Frontiers in Immunology|July 3, 2025
Wuhan strain of SARS-CoV-2 triggers activation of immune evasion machinery similar to the one operated by cancer cellsMaryam Abooali, Inna M Yasinska, Gauri Thapa, et al.
Oncoimmunology|August 14, 2023
L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytesStephanie Schlichtner, Inna M Yasinska, Elena Klenova, et al.
Oncoimmunology|June 7, 2018
High mobility group box 1 (HMGB1) acts as an "alarmin" to promote acute myeloid leukaemia progressionInna M Yasinska, Isabel Gonçalves Silva, Svetlana S Sakhnevych, et al.
Ebiomedicine|July 29, 2017
The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia CellsIsabel Gonçalves Silva, Inna M Yasinska, Svetlana S Sakhnevych, et al.
Nanoscale|March 15, 2018
Highly specific targeting of human acute myeloid leukaemia cells using pharmacologically active nanoconjugatesInna M Yasinska, Giacomo Ceccone, Isaac Ojea-Jimenez, et al.
Aging|December 9, 2020
Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cellsAnette Teo Hansen Selnø, Stephanie Schlichtner, Inna M Yasinska, et al.
Frontiers in Immunology|December 17, 2020
Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic ActivityInna M Yasinska, N Helge Meyer, Stephanie Schlichtner, et al.
Frontiers in Immunology|July 30, 2019
The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast CancerInna M Yasinska, Svetlana S Sakhnevych, Ludmila Pavlova, et al.
Pageof 4